Tarsus Pharmaceuticals, Inc. (TARS)
Nasdaq: TARS · Biological Products, (No Diagnostic Substances) · Irvine, CA · filing with the SEC since 2020
Who runs Tarsus Pharmaceuticals, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Azamian Bobak R.
President/CEO and Board Chair. First filing Oct 2020, latest Sep 9, 2026, 55 filings in all.
Officers reporting now
8
of 15 people with a filing in the last fifteen months
Directors reporting now
7
21 people on the record since 2020
Officerssales are open-market, Nov 5, 2025 to Nov 5, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Clase Neera | Chief Commercial Officer | Nov 2026 | Nov 5, 2026 | none |
| Azamian Bobak R. | President/CEO and Board Chair | Oct 2020 | Sep 9, 2026 | 10 · $5.2M |
| Neervannan Seshadri | Chief Operating Officer | Oct 2020 | Sep 9, 2026 | 6 · $2.0M |
| Lin Elizabeth Yeu | Chief Medical Officer | Jan 2022 | Sep 9, 2026 | 11 · $2.4M |
| Farrow Jeffrey S | Chief Financial Officer and Chief Strategy Officer | Apr 2023 | Jun 17, 2026 | 4 · $1.3M |
| Mottiwala Aziz | Chief Commercial Officer | Oct 2020 | Mar 19, 2026 | 3 · $900,000 |
| Whitfield Dianne C. | Chief Human Resources Officer | Jan 2021 | Mar 19, 2026 | 8 · $2.7M |
| Wahl Bryan | General Counsel | Jan 2021 | Mar 19, 2026 | 3 · $900,000 |
Directorssales are open-market, Nov 5, 2025 to Nov 5, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Link William J Phd | director | Oct 2020 | Sep 17, 2026 | 13 · $4.5M |
| Pyott David E I | director | Feb 2026 | Sep 17, 2026 | none |
| Yarno Wendy L | director | Nov 2020 | Sep 17, 2026 | none |
| Chaudhuri Bhaskar | director | Oct 2020 | Jun 29, 2026 | none |
| Goldberg Andrew D. | director | Oct 2020 | Jun 29, 2026 | none |
| Goodrich Katherine | director | Nov 2024 | Jun 29, 2026 | 1 · $200,000 |
| Morrison Scott W | director | Oct 2022 | Jun 29, 2026 | none |
Earlier names on the record16, newest filing first
Crane Rosemary A · director · last filing Jun 2024Trevejo Jose M. · officer · last filing Dec 2023Greenstein Leonard M. · officer · last filing Apr 2023Holdbrook Mark J. · officer · last filing Mar 2023Ackermann Michael · director · last filing Jul 2022Vivo Capital Fund Ix, L.P. · 10% owner · last filing May 2022Vivo Capital Ix, LLC · 10% owner · last filing May 2022Tester Jason E. · director · last filing Jun 2021Rtw Investments, LP · 10% owner · last filing May 2021Wong Roderick · 10% owner · last filing May 2021Fhmls Ix, L.L.C. · 10% owner · last filing Oct 2020Fhmls Ix, L.P. · 10% owner · last filing Oct 2020Frazier Life Sciences Ix, L.P. · 10% owner · last filing Oct 2020Heron Patrick J · 10% owner · last filing Oct 2020Horowitz Limited Partnership Viii · 10% owner · last filing Oct 2020Topper James N · 10% owner · last filing Oct 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.